NPI: 1770674350 · ELKO, NV 89801 · Rural Acute Care Hospital · NPI assigned 09/27/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 09/27/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 66,075 | $1.20M |
| 2019 | 83,693 | $1.16M |
| 2020 | 67,115 | $952K |
| 2021 | 70,994 | $887K |
| 2022 | 71,780 | $908K |
| 2023 | 67,393 | $835K |
| 2024 | 44,111 | $568K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 19,448 | 12,861 | $1.62M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 22,616 | 16,489 | $1.28M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,540 | 2,895 | $1.19M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,286 | 4,516 | $764K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,069 | 2,761 | $251K |
| G0378 | Hospital observation service, per hour | 1,450 | 821 | $208K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,958 | 4,471 | $160K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 847 | 573 | $154K |
| 72125 | Computed tomography, cervical spine; without contrast material | 695 | 488 | $122K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 493 | 309 | $85K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 766 | 431 | $80K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,769 | 1,425 | $52K |
| 80053 | Comprehensive metabolic panel | 30,181 | 18,674 | $51K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 8,048 | 4,080 | $51K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,612 | 5,429 | $34K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 396 | 345 | $30K |
| 96375 | Therapeutic injection; each additional sequential IV push | 12,333 | 7,291 | $29K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,914 | 1,704 | $27K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,135 | 1,837 | $25K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,130 | 1,831 | $22K |
| 80055 | 396 | 355 | $19K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7,787 | 5,055 | $17K |
| 41899 | Unlisted procedure, dentoalveolar structures | 28 | 28 | $14K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,063 | 1,123 | $14K |
| 59025 | Fetal non-stress test | 687 | 479 | $13K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12,655 | 8,234 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,284 | 5,903 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 204 | 169 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 33,013 | 20,244 | $12K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 672 | 427 | $11K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 181 | 145 | $11K |
| 84702 | 2,519 | 1,713 | $9K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 159 | 131 | $9K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 164 | 138 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 8,767 | 6,115 | $8K |
| 71046 | Radiologic examination, chest; 2 views | 2,538 | 1,974 | $7K |
| 72131 | 43 | 39 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 5,125 | 3,174 | $5K |
| 83880 | 3,275 | 2,018 | $5K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 4,475 | 3,100 | $4K |
| 80050 | General health panel | 167 | 165 | $3K |
| 96376 | 3,935 | 2,188 | $3K | |
| 87070 | 902 | 647 | $3K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 151 | 27 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 7,060 | 4,425 | $3K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 959 | 751 | $3K |
| 0001A | 114 | 95 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 16 | 13 | $2K |
| 71045 | Radiologic examination, chest; single view | 8,643 | 5,423 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | 12,630 | 7,396 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | 3,597 | 2,813 | $2K |
| 80061 | Lipid panel | 2,040 | 1,738 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 180 | 138 | $2K |
| 87040 | 3,134 | 1,391 | $2K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 86 | 84 | $2K |
| 36415 | Collection of venous blood by venipuncture | 13,623 | 9,744 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,647 | 2,434 | $1K |
| 87186 | 4,371 | 2,897 | $1K | |
| 85610 | 3,405 | 2,033 | $1K | |
| 0002A | 97 | 76 | $1K | |
| 84439 | 1,064 | 922 | $887.77 | |
| 76830 | Ultrasound, transvaginal | 38 | 28 | $863.35 |
| 93971 | 24 | 14 | $789.03 | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 160 | 24 | $772.75 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,750 | 1,247 | $760.44 |
| 84484 | 7,807 | 3,953 | $735.27 | |
| 73564 | 226 | 183 | $669.31 | |
| 85730 | 1,864 | 1,225 | $593.56 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 400 | 273 | $573.17 |
| 73610 | 331 | 266 | $529.52 | |
| 83690 | 8,087 | 5,121 | $454.09 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,220 | 1,818 | $441.14 |
| 82947 | 3,127 | 1,604 | $404.49 | |
| 84703 | 3,267 | 2,338 | $317.90 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,770 | 2,788 | $314.76 |
| 87420 | 301 | 252 | $313.83 | |
| 83605 | 3,166 | 1,733 | $312.99 | |
| J2704 | Injection, propofol, 10 mg | 2,820 | 1,820 | $308.57 |
| 80179 | 1,275 | 937 | $307.56 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 516 | 301 | $301.64 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 3,476 | 2,102 | $294.32 |
| 83655 | 28 | 26 | $288.44 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 695 | 606 | $280.57 |
| 80143 | 1,316 | 957 | $279.60 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 40 | 28 | $275.54 |
| 87428 | 854 | 642 | $264.53 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 7,136 | 4,084 | $263.84 |
| 73130 | 153 | 106 | $257.55 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,901 | 2,655 | $249.72 |
| 85027 | 1,319 | 883 | $244.32 | |
| 81025 | 3,914 | 2,896 | $231.91 | |
| 81003 | 10,327 | 7,199 | $220.06 | |
| 87430 | 2,491 | 2,034 | $219.71 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,825 | 4,857 | $205.68 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,506 | 1,136 | $193.34 |
| 82950 | 299 | 286 | $168.93 | |
| 87581 | 1,043 | 783 | $167.58 | |
| 87486 | 1,041 | 783 | $167.58 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1,050 | 781 | $167.58 |
| 87081 | 2,686 | 2,279 | $149.49 | |
| 87077 | 4,371 | 2,898 | $144.09 | |
| 73030 | 80 | 53 | $143.45 | |
| 82565 | 1,168 | 741 | $141.72 | |
| 85379 | 2,108 | 1,341 | $132.89 | |
| 74018 | 80 | 59 | $131.99 | |
| 73630 | 207 | 146 | $131.81 | |
| 81001 | 8,827 | 5,843 | $126.37 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 13,879 | 8,232 | $125.23 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 730 | 481 | $118.50 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,656 | 2,083 | $118.37 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 218 | 141 | $117.20 |
| 83735 | 1,376 | 770 | $115.62 | |
| 82150 | 2,705 | 1,868 | $111.90 | |
| 87899 | 205 | 181 | $110.87 | |
| 84520 | 688 | 432 | $103.73 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 84 | 70 | $94.69 |
| 72100 | 66 | 63 | $93.23 | |
| 86140 | 1,978 | 1,458 | $76.68 | |
| J2060 | Injection, lorazepam, 2 mg | 4,470 | 2,520 | $74.37 |
| 90715 | 127 | 69 | $69.16 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,810 | 1,680 | $66.65 |
| J1630 | Injection, haloperidol, up to 5 mg | 1,956 | 1,116 | $59.72 |
| 84145 | 504 | 301 | $54.81 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 148 | 84 | $44.44 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,218 | 1,878 | $40.44 |
| 82550 | 764 | 508 | $31.02 | |
| 86850 | 259 | 181 | $28.67 | |
| 82553 | 807 | 543 | $22.77 | |
| 86803 | 186 | 173 | $22.15 | |
| 84436 | 586 | 393 | $18.76 | |
| 86701 | 205 | 181 | $17.52 | |
| 82728 | 14 | 12 | $14.61 | |
| 86677 | 311 | 239 | $12.21 | |
| 86780 | 116 | 102 | $11.70 | |
| 85652 | 218 | 139 | $9.08 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 161 | 111 | $9.08 |
| 87205 | 185 | 140 | $8.73 | |
| 85007 | 934 | 672 | $8.50 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,564 | 1,606 | $7.85 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,052 | 619 | $6.97 |
| 86901 | 827 | 531 | $6.12 | |
| 86900 | 827 | 531 | $6.12 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 255 | 203 | $5.20 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,225 | 725 | $4.45 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,626 | 1,571 | $2.64 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 437 | 280 | $2.11 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,236 | 2,015 | $1.28 |
| J1171 | Injection, hydromorphone, 0.1 mg | 28 | 22 | $0.90 |
| J7050 | Infusion, normal saline solution, 250 cc | 186 | 89 | $0.70 |
| J3230 | Injection, chlorpromazine hcl, up to 50 mg | 45 | 37 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 192 | 163 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 27 | 24 | $0.00 |
| A9270 | Non-covered item or service | 3,944 | 1,924 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 297 | 176 | $0.00 |
| 0012A | 135 | 109 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 118 | 112 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 49 | 25 | $0.00 |
| 87507 | 98 | 68 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 615 | 399 | $0.00 |
| 0011A | 174 | 123 | $0.00 | |
| 91301 | 91 | 88 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 26 | 13 | $0.00 |
| 96368 | 17 | 12 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 21 | 13 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 19 | 13 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 27 | 15 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 146 | 90 | $0.00 |
| 84550 | 34 | 28 | $0.00 | |
| 84100 | 76 | 44 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 154 | 90 | $0.00 |
| 84156 | 16 | 14 | $0.00 | |
| 85378 | 179 | 146 | $0.00 | |
| 82248 | 40 | 19 | $0.00 | |
| 91300 | 113 | 76 | $0.00 | |
| 96367 | 35 | 25 | $0.00 | |
| 82570 | 14 | 12 | $0.00 |